Are Investors Getting Enough From the Microsemi Acquisition?
Shares of Microsemi saw a handy gain to close out the week after it was announced that the company would be acquired by Microchip Technology.
All Work
Chris Lange
If You Invested $1000 in Goldman Sachs at the Market Bottom, Now It Would Be Worth $3500
The S&P 500 has more than quadrupled since its bottom nearly nine years ago. So how does this stack up against Goldman Sachs?
Can Sprint Change Its Luck With Half-Priced iPhone Xs?
The big four U.S. telecoms have been waging a war for dominance in the field for quite some time, and now Sprint is pulling out the big guns.
If You Invested $1000 in Intel at the Market Bottom, Now It Would Be Worth $5150
The S&P 500 has more than quadrupled since its bottom nearly nine years ago. So how does this stack up against Intel?
If You Invested $1000 in Verizon at the Market Bottom, Now It Would Be Worth $2900
The S&P 500 has more than quadrupled since its bottom nearly nine years ago. So how does this stack up against Verizon?
Are Investors Overreacting to Foot Locker Earnings?
Foot Locker released its fourth-quarter financial results before the markets opened on Friday, and investors have voted with their shares and sent the stock lower.
Why Gap Earnings (and Guidance) Are So Great
The Gap, Inc. (NYSE: GPS) released its fiscal fourth quarter financial results after the markets closed on Thursday. The company said that it had $0.61 in earnings per share (EPS) on $4.8 billion in…
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a very down day for the broad U.S. markets with all three of the major exchanges closing significantly lower on the day. The Dow took the worst of the punishment with losses…
Can GameStop Pick Up Where Best Buy Left Off?
Best Buy intends to close all of its remaining Best Buy Mobile stand-alone stores, a big opportunity for the likes of GameStop.
What Is Driving JC Penney Shares Down Ahead of Earnings?
J.C. Penney saw its shares drop on Thursday despite no major news for the company coming out. Its earnings report is due Friday morning.
If You Invested $1000 in IBM at the Market Bottom, Now It Would Be Worth $1815
The S&P 500 has more than quadrupled since its bottom nearly nine years ago. So how does this stack up against IBM?
Is This the Last Chapter for Barnes & Noble?
Barnes & Noble released its most recent quarterly results before the markets opened on Thursday, and this was met with investor trepidation.
If You Invested $1000 in Berkshire Hathaway at the Market Bottom, Now It Would Be Worth $4250
The S&P 500 has more than quadrupled since its bottom nearly nine years ago. So how does this stack up against Berkshire Hathaway?
If You Invested $1000 in Disney at the Market Bottom, Now It Would Be Worth $7350
The S&P 500 has more than quadrupled since its bottom nearly nine years ago. So how does this stack up against Disney?
Are Investors Giving Kohl’s Enough Credit?
Kohl’s reported better-than-expected fiscal fourth-quarter financial results before the markets opened on Thursday.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was another down day for the broad U.S. markets with all three of the major exchanges closing lower on the day. The Dow took the worst of the punishment with its losses over…
With a $1 Target Price, Is MannKind at Risk of Bankruptcy?
MannKind Corp. (NASDAQ: MNKD) has been under fire from Wall Street for quite some time and is no stranger to the cold shoulder of analysts. Although, its shares did tumble in Wednesday’s session after…
If You Invested $1,000 in Caterpillar at the Market Bottom, Now It Would Be Worth $9,000
One of the most difficult parts of trading is timing the markets, although in a bull market this is less of a problem. But it can be particularly difficult calling the market bottom in…
Why Square Is Firmly Among Top Battleground Stocks After Earnings and Analyst Updates
Square just became a confirmed battleground stock in which it is unclear if the bulls or the bears are going to win.
Why the Celgene Damage May Be an Overreaction
Celgene watched its shares drop on Wednesday after the company announced that it received a Refusal to File letter from the FDA.